NEW YORK, Jan. 20, 2020 /PRNewswire/ --
The infertility treatment market is expected to grow at a CAGR
of over 6% during the forecast period 2018–2024.
Read the full report:
https://www.reportlinker.com/p05839999/?utm_source=PRN
The growing prevalence of infertility among men and women is
increasing the demand for sterility treatment globally. Factors
such as delayed parenthood, obesity, sexually transmitted
infections (STIs), and aging is increasing sterility incidences
among married couples worldwide.
The increasing acceptance of advanced and sophisticated medical
care options such as ART and IVF is likely to drive the market. The
globalization of healthcare facilities and the increasing
popularity of medical tourism, especially fertility tourism,
encourage several couples to travel abroad to seek state-of-the-art
medical care options. The reimbursement coverage is also improving
globally, and many countries cover fertility treatment as part of
respective public health coverage programs
The following factors are likely to contribute to the growth of the
infertility treatment market during the forecast period:
• Increasing Prevalence of Infertility
• Growing Number of Obesity Cases
• Increasing Number of Facilities offering Fertility Services
• Increasing Financial Assistance Programs
• Growing popularity for Fertility Tourism
The study considers the present scenario of the global infertility
treatment market and its market dynamics for the period 2018?2024.
It covers a detailed overview of several market growth enablers,
restraints, and trends. The study offers both the demand and supply
aspects of the market. It profiles and examines leading companies
and other prominent companies operating in the market.
Infertility Treatment Market: Segmentation
This research report includes detailed segmentation by product,
procedure, end-user, cause, and geography. Treatment by drugs has
been dominating the infertility treatment market because it is a
cost-effective measure and is considered to be the first choice
among people to be treated. The acceptance of gonadotropin drugs
for treatment is driving the segment significantly and is likely to
witness steady growth during the forecast period. However, the
surge in the prevalence of sterility, advances IVF devices
technology, the increasing trend of delayed pregnancies, and the
growth in disposable income are the major factors driving the
infertility treatment devices market. Globally, the IVF treatments
are witnessing an improvement in overall success rates majorly due
to the availability of a broad range of culture media. The
consumables segment is rapidly increasing due to the increasing
effectiveness of ART procedures and surgical interventions that
create huge demand for consumables and is expected to grow by
2024.
The medication segment is the largest contributor due to a wide
range and usage. The increasing approval of fertility services and
cultural shifts has led to a high demand for medication and
treatments. The awareness of sterility treatment has increased over
time, thereby reducing the reluctance of people to opt for
medication. ART is the fastest growing procedure on account of the
high acceptance of this treatment because of the improvement in
success rate and advanced techniques to cure sterility. The
favorable financial support for ART procedures in both developed
and emerging countries is another factor contributing to the
growth. However, the segment is likely to witness hindrance due to
the high cost of ART procedures.
The fertility clinics dominate the market due to the high success
rate of fertility services and IVF clinics. The number of fertility
services is expanding across the globe. These clinics occupy the
largest share in the infertility treatment market owing to the
availability and accessibility of different services such as IVF
programs, egg donation, ICSI, IMSI, and other services. The segment
is projected to hold the highest share during the forecast period
due to the constant rise in clinics and increasing partnerships of
clinics with fertile consultants and experts.
The female infertility segment is contributing significantly to the
market due to the high prevalence of female infertility globally.
The increase in the target pool of female patients and the growing
number of dedicated fertility clinics are the major factors driving
the growth of the segment. The prevalence of male sterility is
increasing worldwide due to changes in lifestyle patterns, an
increase in the consumption of alcohol and smoking, and an increase
in the prevalence of obesity. All these factors affect sperm counts
and their quality, thereby increasing the occurrence among men.
Market Segmentation by Product
• Drugs
o Gonadotropins
o Other Drugs
• Devices
o Equipment
o Media
o Consumables
Market Segmentation by Procedure
• Drug Therapy
• ART Procedure
• Surgical Intervention
Market Segmentation by End-user
• Infertility Clinics
• Hospitals
• Gynecological & Urology Clinics
• Others
Market Segmentation by Cause
• Female Infertility
• Male Infertility
• Others
Insights by Geography
Europe is the major region, which
is leading the market and is expected to bolster its dominance
during the forecast period because the region is going through a
phase of reduction in population and is seriously considering
tackling this sociological phenomenon. The demand for fertility
services is increasing rapidly in North
America due to the growing prevalence of sterility, the
presence of the aging population and the high occurrence of
obesity. These factors are likely to generate significant demand
for fertility services in the future. APAC is growing at a steady
pace owing to the shifting mean age among women during their first
childbirth and the increasing sterility among people in developing
countries. Latin America is
witnessing a rise in sterility among men and women and decreasing
fertility rates in the population, which is likely to increase the
demand for fertility services. MEA faces a low healthcare facility,
a lack of specialized health care professionals, and inadequate
awareness of fertility medical care. However, with the growing
awareness and development of advanced technology, the region is
expected to drive the infertility treatment market in the
region.
Market Segmentation by Geography
• Europe
o Spain
o France
o Germany
o UK
o Italy
• North America
o Canada
o US
• APAC
o China
o Japan
o South Korea
o India
o Australia
• Latin America
o Brazil
o Argentina
o Mexico
• MEA
o Turkey
o Israel
Insights by Vendors
There are a few global and several local and regional vendors
offering medicines, devices, and equipment for treatment. The
fertility drugs market is highly concentrated with key
pharmaceuticals accounting for commendable shares. However, the
other fertility drugs market is highly fragmented with many local
and domestic companies are offering a wide array of low-cost drugs
in their respective countries. The market is competitive due to the
availability of several low-cost drugs. Companies offering
fertility drugs are registering impressive growth rates for their
products due to the increased uptake of these drugs.
Key Vendors
• The Cooper Companies
• Cook Medical
• Vitrolife
• Ferring Pharmaceuticals
• IVFtech
• Irvine Scientific
• Merck KGaA
Other Vendors
• Abbott
• Sanofi
• Salix Pharmaceuticals
• Microtech IVF
• Novartis
• Hamilton Thorne
• The Merck Co
• Thermo Fisher Scientific
• INVO Bioscience
• MedGyn Products
• SOMATEX Medical Technologies
• CARL ZEISS
Key Market Insights
The analysis of the infertility treatment market provides sizing
and growth opportunities for the forecast period 2019–2024.
• Provides comprehensive insights on the latest industry trends,
forecast, and growth drivers in the market.
• Includes a detailed analysis of growth drivers, challenges, and
investment opportunities.
• Delivers a complete overview of segments and the regional outlook
of the infertility treatment market.
• Offers an exhaustive summary of the vendor landscape, competitive
analysis, and key strategies to gain competitive advantage.
Read the full report:
https://www.reportlinker.com/p05839999/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original
content:http://www.prnewswire.com/news-releases/the-infertility-treatment-market-is-expected-to-grow-at-a-cagr-of-over-6-during-the-forecast-period-20182024-300989530.html
SOURCE Reportlinker